We are live on
!
Find out more
Asset Management One Portfolio holdings
AUM
$39B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
+0.12%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.82%
5 Year Est. Return
+143.22%
10 Year Est. Return
+503.7%
AUM
$7.24B
AUM Growth
+$542M
(+8.1%)
Cap. Flow
+$601M
Cap. Flow
% of AUM
8.29%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
1,322
New
166
Increased
421
Reduced
404
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$23M |
| 2 |
Gilead Sciences
GILD
|
+$18.6M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$17.3M |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$16.3M |
| 5 |
Biogen
BIIB
|
+$14.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Tower
AMT
|
+$20M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$13.1M |
| 3 |
RTN
Raytheon Company
RTN
|
+$10.6M |
| 4 |
LLL
L3 Technologies, Inc.
LLL
|
+$10.5M |
| 5 |
Regency Centers
REG
|
+$9.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 30.07% |
| 2 | Healthcare | 13.94% |
| 3 | Technology | 8.1% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIV
126
Aimco
AIV
$383M
| $13.9M | 0.19% |
3,265,925
-202,676
| -6% | -$903K |
|
127
Medtronic
MDT
$110B
| $13.2M | 0.18% |
211,828
+93,556
| +79% | +$5.95M |
|
|
APC
128
DELISTED
Anadarko Petroleum
APC
| $13.1M | 0.18% |
125,892
+26,825
| +27% | +$2.89M |
|
129
NNN REIT
NNN
$9.16B
| $13.1M | 0.18% |
373,452
-14,555
| -4% | -$532K |
|
|
ALXN
130
DELISTED
Alexion Pharmaceuticals
ALXN
| $13M | 0.18% |
77,428
+50,176
| +184% | +$8.24M |
|
|
DHC
131
Diversified Healthcare Trust
DHC
$2.17B
| $12.9M | 0.18% |
618,550
-29,112
| -4% | -$660K |
|
|
SRC
132
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $12.9M | 0.18% |
262,641
+1,860
| +0.7% | +$96.1K |
|
133
Omega Healthcare
OHI
$15B
| $12.8M | 0.18% |
377,947
-18,353
| -5% | -$675K |
|
|
CSC
134
DELISTED
Computer Sciences
CSC
| $12.8M | 0.18% |
496,265
+4,708
| +1% | +$121K |
|
135
United Therapeutics
UTHR
$26.2B
| $12.6M | 0.17% |
97,756
-7,202
| -7% | -$742K |
|
136
Broadcom
AVGO
$1.85T
| $12.5M | 0.17% |
1,435,970
+679,950
| +90% | +$5.31M |
|
137
Capital One
COF
$129B
| $12.4M | 0.17% |
152,227
+77,000
| +102% | +$6.3M |
|
138
American Homes 4 Rent
AMH
$11.9B
| $12.3M | 0.17% |
718,150
+570,819
| +387% | +$10.2M |
|
139
Colgate-Palmolive
CL
$73.3B
| $12.2M | 0.17% |
186,360
-39,590
| -18% | -$2.61M |
|
140
CME Group
CME
$96.1B
| $12.2M | 0.17% |
153,107
+78,192
| +104% | +$5.89M |
|
|
SVC
141
Service Properties Trust
SVC
$1.04B
| $12.1M | 0.17% |
89,995
-5,056
| -5% | -$732K |
|
142
CoreCivic
CXW
$2.95B
| $12.1M | 0.17% |
344,135
-19,132
| -5% | -$658K |
|
143
Ironwood Pharmaceuticals
IRWD
$614M
| $11.9M | 0.16% |
+1,065,114
| New | +$12.2M |
|
144
Lowe's Companies
LOW
$118B
| $11.7M | 0.16% |
220,263
-2,048
| -0.9% | -$103K |
|
145
RLJ Lodging Trust
RLJ
$1.87B
| $11.6M | 0.16% |
403,055
-10,350
| -3% | -$302K |
|
146
Vertex Pharmaceuticals
VRTX
$122B
| $11.5M | 0.16% |
101,388
+75,072
| +285% | +$7.15M |
|
147
Jazz Pharmaceuticals
JAZZ
$16.2B
| $11.5M | 0.16% |
71,153
+54,457
| +326% | +$8.37M |
|
148
Aon
AON
$78.3B
| $11.5M | 0.16% |
131,536
+93,214
| +243% | +$8.14M |
|
149
Targa Resources
TRGP
$57.6B
| $11.4M | 0.16% |
83,330
-16,292
| -16% | -$2.24M |
|
150
Alaska Air
ALK
$5.27B
| $11.4M | 0.16% |
260,791
-23,405
| -8% | -$1.09M |
|
Similar funds
Asset Management One's Q3 2014 Portfolio in Review
As of Q3 2014, Asset Management One held 1,322 positions worth $7.24B, up 8.1% from $6.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Asset Management One deployed $601M of net new capital in Q3 2014, opening 166 new positions and adding to 421 existing holdings. Its largest new stake was Ironwood Pharmaceuticals: 1,065,114 shares worth $11.9M.
By sector, the portfolio is most concentrated in Real Estate at 30% of assets, down from 34% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was American Tower, an estimated $20M trimmed.
- Asset Management One's largest Q3 2014 buy was Ironwood Pharmaceuticals: 1,065,114 shares worth $11.9M.
- Asset Management One added most to AbbVie in Q3 2014, an estimated $23M increase.
- Asset Management One's biggest Q3 2014 reduction was American Tower, cutting an estimated $20M.
- Asset Management One fully exited Orbital ATK, Inc. in Q3 2014, selling an estimated $9.2M.
- Asset Management One's ten largest holdings make up 14% of its $7.24B portfolio in Q3 2014.
- Asset Management One opened 166 new positions and closed 77 in Q3 2014.
- Asset Management One's portfolio value rose 8.1% quarter-over-quarter to $7.24B.
Based on Asset Management One's 13F filing for Q3 2014, filed 5 Nov 2014.